Whitehead, S. S., Durbin, A. P., Pierce, K. K., Elwood, D., McElvany, B. D., Fraser, E. A., . . . Kirkpatrick, B. D. (2017). In a randomized trial, the live attenuated tetravalent dengue vaccine TV003 is well-tolerated and highly immunogenic in subjects with flavivirus exposure prior to vaccination. PLoS Negl Trop Dis.
Stile di citazione ChicagoWhitehead, Stephen S., et al. "In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects With Flavivirus Exposure Prior to Vaccination." PLoS Negl Trop Dis 2017.
Citazione MLAWhitehead, Stephen S., et al. "In a Randomized Trial, the Live Attenuated Tetravalent Dengue Vaccine TV003 Is Well-tolerated and Highly Immunogenic in Subjects With Flavivirus Exposure Prior to Vaccination." PLoS Negl Trop Dis 2017.